Skip to content

An Integrative Approach to Migraine Treatment Using the Tri-chat Herbal Essential Oil Formula : a randomized controlled trial

Evaluating the Effects of Massage and Herbal Therapies on Migraine Symptoms: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250707010
Enrollment
75
Registered
2025-07-07
Start date
2025-05-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine patient Migraine , Essential oil , Massage therapy, Tri Chat, Thai medicine

Interventions

Ibuprofen 200 mg take only when experiencing migraine headache symptoms.,Thai massage therapy for migraine for 3 times per week and Placebo oil inhalation,Thai massage therapy for migraine for 3 times
Active Comparator Drug,Placebo Comparator Other,Experimental Drug
Ibuprofen medication ,Traditional massage therapy combined with a placebo inhalant ,Traditional massage therapy combined with an essential oil Tri chat formulation based on the TriChat traditional Th

Sponsors

-
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age between 20 and 55 years. 2. Diagnosed with migraine according to the International Classification of Headache having a history of migraine for at least 12 months, with fewer than 14 headache days per month and at least 2 migraine days in the 3 months prior to screening. 3. Experiencing mild to moderate headache intensity. 4. Fully conscious and able to communicate effectively. 5. Willing to participate voluntarily and provide informed consent. 6. Not diagnosed with hypertension. 7. Not currently taking anticoagulant medications.

Exclusion criteria

Exclusion criteria: 1. Systolic blood pressure exceeding 160 mmHg and or diastolic blood pressure exceeding 100 mmHg. 2. Body temperature greater than 37.5 C 3. Presence of open wounds or active infections in the cervical, shoulder, or upper back regions. 4. Diagnosed with osteoporosis, cervical spondylosis, or bone malignancies.

Design outcomes

Primary

MeasureTime frame
Evaluate the degree of disability and symptom severity resulting from migraine, administered post treatment at 7 day and 14 day Migraine Disability Assessment, Pain score at 7 day and 14 day Numerical Rating Scale,Migraine Symptom Diary:Including frequency duration and characteristics of migraine episodes at 7 day and 14 day frequency and duration

Secondary

MeasureTime frame
Quality of life at 14 day Europe 5-Dimension 5-LeveEQ-5D-5L Thai Version To assess the participants healthrelated quality of life

Countries

Thailand

Contacts

Public ContactRatchadawan Aukkanimart

Rajamangala University of Technology Isan

Ratchadawan.au@rmuti.ac.th0854611959

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026